Statements & Speeches

• Statement – June 19, 2008
  Statement from Rx&D President Russell Williams on the release of the Patented Medicine Prices Review Board Report (PMPRB) 2007. Read More
  
  
• Statement– May 15 2008
  Statement from Rx&D president Russell Williams on the release of the CIHI report on drug spending in 2007. Read More
  


• Speech – May 13, 2008
  Speech by Rx&D President Russell Williams before the House of Common Standing Committee on Health on the 10-year plan to strengthen health care. Read More
  
  
• Statement – February 27, 2008
  Rx&D president Russell Williams commends the federal government on its budget 2008 for supporting health sciences research. Read More
   
• Speech – February 05, 2008
  Speech of Dr. Pier-Giorgio Fontana on behalf of Rx&D before the House of Commons Standing Committee on Health about post-market surveillance of pharmaceuticals. Read More
   
• Message – February 1st, 2008
  Message from Ronnie Miller, Chairman of the Board, Rx&D congratulating Université Laval upon the launch of a new web site celebrating Quebec City’s 400th anniversary. Read More
   
• Speech - November 29, 2007
  Presentation to the House of Commons Standing Committee on Finance Pre-Budget Consultations held in Ottawa. Read More
   
• Speech - Montreal, November 15, 2007
  “A Bridge to Prosperity in a New Century.” Canada’s 18th Prime Minister and HRF Medal of Honour winner, the Right Honourable Brian Mulroney, describes how innovative policies improve the lives of Canadians. Read More
   
• Speech - September 27, 2007
  Mr. Philip Blake, Chairman of Canada’s Research Based Pharmaceutical Companies (Rx&D) and President of Bayer Canada addresses the BioPort Atlantic 2007 Conference about building a strong life-sciences sector in Atlantic Canada. Read More
   
• Statement – July 20, 2007
  Statement from Rx&D President Russell Williams on the release of the Patented Medicine Prices Review Board Report (PMPRB) 2006. Read More
   
• Statement - May 17, 2007
  Rx&D President Russell Williams commends the federal government on its announcement of a science and technology strategy for Canada. Read More
   
• Speech - April 23, 2007
  Remarks of Russell Williams, President, Rx&D and Terry Mc Cool, Vice President, Eli Lilly Canada Inc. before the House of Commons Standing Committee Industry Science and Technology. The Committee is currently reviewing Canada's Access to Medicines Regime legislation. Read More
   
• Speech - April 16, 2007
  Speech of Rx&D President Russell Williams before the House of Commons Standing Committee on Health that is evaluating the effectiveness of the Common Drug Review (CDR). Read More
   
• Statement - March 20, 2007
  Canadians Will Benefit From Focus on Health Sciences in Federal Budget, says Rx&D. Read More
   
• Statement - February 20, 2007
  Rx&D commends the Government of Canada and its partnership with the Bill and Melinda Gates Foundation to develop globally accessible HIV vaccines. Read More
   
• Speech - February 16, 2007
  Rx&D Board Chairman, Mr. Philip Blake, delivered remarks at the official opening of Health Partners International of Canada's Distribution Centre in Mississauga Ontario. Read More
   
• Statement - February 1, 2007
     Rx&D reacts to Quebec's Drug Policy. Read more
  Key facts on the research-based pharmaceutical industry in Quebec. Read more